Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
To examine whether the occurrence of oral mucositis can be reduced by dental oral management
in patients by comparing the use of dental oral management through instruction by dental and
oral surgeons (dental oral management group) and an observation group (brushing instruction
only group) in a randomized, controlled study in females that are using everolimus for
estrogen receptor-positive, hormone therapy-resistant refractory breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Comprehensive Support Project for Oncology Research